BEMFOLA®, a recombinant-human Follicle Stimulating Hormone (r hFSH) commercialised by Gedeon Richter, is a biosimilar to GONAL-f®, an established reference product. BEMFOLA® is produced using recombinant DNA technology. Both BEMFOLA® and the reference product GONAL-f® are formulations of the naturally occurring hormone FSH, which plays a key role in human reproduction.

BEMFOLA®is used to treat the following groups:

BEMFOLA® is supplied in a single-use, unique, state-of-the-art delivery system which results in a simple, once-a-day disposable device, allowing the patient to self-inject. BEMFOLA® is available in 5 single use monodose presentations available in the following dosage forms: 75, 150, 225, 300 and 450 IU.

BEMFOLA® was the first biosimilar r-hFSH launched in Europe.

For further information please contact Genpharm at: or by calling +971 4 422 7010